KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Change in Cash (2016 - 2025)

Historic Change in Cash for Bristol Myers Squibb (BMY) over the last 17 years, with Q4 2025 value amounting to -$5.5 billion.

  • Bristol Myers Squibb's Change in Cash fell 32444.99% to -$5.5 billion in Q4 2025 from the same period last year, while for Dec 2025 it was -$129.0 million, marking a year-over-year increase of 8899.32%. This contributed to the annual value of -$129.0 million for FY2025, which is 8899.32% up from last year.
  • Bristol Myers Squibb's Change in Cash amounted to -$5.5 billion in Q4 2025, which was down 32444.99% from $3.1 billion recorded in Q3 2025.
  • Over the past 5 years, Bristol Myers Squibb's Change in Cash peaked at $4.0 billion during Q4 2023, and registered a low of -$5.5 billion during Q4 2025.
  • In the last 5 years, Bristol Myers Squibb's Change in Cash had a median value of -$100.5 million in 2021 and averaged -$237.8 million.
  • Its Change in Cash has fluctuated over the past 5 years, first surged by 59442.23% in 2021, then crashed by 223026.32% in 2022.
  • Bristol Myers Squibb's Change in Cash (Quarter) stood at $437.0 million in 2021, then surged by 213.04% to $1.4 billion in 2022, then skyrocketed by 188.82% to $4.0 billion in 2023, then tumbled by 37.89% to $2.5 billion in 2024, then crashed by 324.45% to -$5.5 billion in 2025.
  • Its Change in Cash stands at -$5.5 billion for Q4 2025, versus $3.1 billion for Q3 2025 and $1.7 billion for Q2 2025.